Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis and haemostasis"
DOI: 10.1055/a-1414-5216
Abstract: Background Sulodexide has pleiotropic properties within the vascular endothelium that can prove beneficial for the treatment of patients with COVID-19. We aimed to evaluate the effect of sulodexide when used in the early clinical stages… read more here.
Keywords: randomized controlled; group; treatment patients; controlled trial ... See more keywords